This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...

The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...

The agency wants applicants to demystify their algorithms and provide specific details about what the models do, how they’re ...

In a strategic move to expand its footprint in the healthcare sector, Advanced Micro Devices (AMD) has announced a $20 ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, ...

AMD's technology will also be used to boost Absci's drug discovery workload, including the company's de novo antibody design ...